Evonik Industries AG annual ebitda
2022
2023
2024
2025
Evonik Industries AG EBITDA Growth & History (EVK)
Evonik Industries AG's calculated EBITDA was €1.84B for fiscal 2025.
View full Evonik Industries AG company overviewEvonik Industries AG annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.84B | €80.0M | +4.54% |
| 2024 | 2024-12-31 | €1.76B | €29.0M | +1.67% |
| 2023 | 2023-12-31 | €1.73B | −€879.0M | −33.64% |
| 2022 | 2022-12-31 | €2.61B | — | — |
Evonik Industries AG quarterly ebitda
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €553.0M | €45.0M | +8.86% |
| Q1 2026 | 2026-03-31 | €473.0M | −€88.0M | −15.69% |
| Q4 2025 | 2025-12-31 | €367.0M | — | — |
| Q2 2025 | 2025-06-30 | €508.0M | — | — |
| Q1 2025 | 2025-03-31 | €561.0M | — | — |
Evonik Industries AG ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Evonik Industries AG's ebitda decreased from €2.61B to €1.84B, a change of −€770.0M. The latest reported quarter, Q2 2026, shows €553.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evonik Industries AG source filings ↗Community posts
Evonik declines takeover negotiations after BASF improves its approach
Evonik ($EVK)’s executive board declined to enter takeover negotiations with BASF ($BAS) after reviewing the larger chemicals group’s renewed approach. Reuters reported that the improved proposal values Evonik at €24 a share, or approximate ...
Evonik reportedly rejects BASF’s €10.3 billion takeover approach
Evonik ($EVK) has rejected a BASF ($BAS) takeover proposal worth approximately €10.3 billion, or €22.15 per share, as inadequate, according to Reuters sources. BASF said its approach remained disciplined and that assessing potential synergi ...
